Enhanced Imaging for Visual Prostheses
视觉假肢的增强成像
基本信息
- 批准号:10483085
- 负责人:
- 金额:$ 73.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:BusinessesClinical TrialsCollaborationsColorCommunitiesComputer softwareDataDevelopmentDiabetic RetinopathyDiseaseDoctor of PhilosophyDocumentationElectric StimulationEnvironmentEvaluationEyeEye InjuriesFinancial compensationFundingGlaucomaGrantHeadHomeImageImage EnhancementImageryIndividualInstitutesInstructionLeadLightMacular degenerationMedicalMedical ElectronicsModalityOcular ProsthesisOphthalmologyPanthera leoParticipantPenetrationPersonsPhasePilot ProjectsPrincipal InvestigatorProcessProductionProsthesisReadinessRehabilitation CentersRehabilitation therapyResearchResolutionRetinaRetinitis PigmentosaSelf-Help DevicesSiliconSmall Business Innovation Research GrantSoftware ValidationSystemTechniquesTechnologyTemperatureTest ResultTestingTimeTrainingTraining ProgramsTranslatingTraumaUniversitiesVisible RadiationVisionVision researchVisualVisual CortexVisual PerceptionVisual impairmentVisually Impaired PersonsWorkbaseblindcohortcommercializationdesignexperienceimagerimaging modalityimaging systemimprovedintelligent algorithmmedical schoolsmultidisciplinaryoptic nerve disorderprogramsprosthesis wearerprototyperetina implantationretinal prosthesissensorverification and validationvision aidvision rehabilitation
项目摘要
Project Summary/Abstract
The proposed project relates to the commercialization of a promising new thermal/visual imaging system to be
used as an input modality to visual prostheses and other low vision aids. Visual prostheses, including Second
Sight's Argus® II retinal prosthesis, which restores partial vision to people blinded by diseases such as retinitis
pigmentosa and macular degeneration, and Second Sight's Orion® visual cortical prosthesis, which restores
partial vision to people blinded by diseases such as retinitis pigmentosa, macular degeneration, glaucoma,
diabetic retinopathy, eye injury/trauma, optic nerve disease etc., use cameras or other sensors to provide
electrical stimulation directly to the retina or visual cortex of the user to elicit visual perception. Unfortunately,
ordinary light and color information is difficult for wearers to effectively process in many important tasks with
the limited perceived spatial resolution of the prostheses and other low vision aids. Current compensation
techniques in reduced resolution systems apply enhancement, magnification, and panning of visible light
imagery, and these techniques have utility. However, as we have convincingly demonstrated in phases I and II
of the SBIR-supported development project, other types of imaging more naturally align with the limited
resolution of visual prostheses in important tasks such as people finding and mobility. In this proposed CRP
project, we will advance the phase II developed production-prototype system into commercial production and
complete all required verification and validation testing to achieve FDA approval. Completed production
systems will be distributed to prosthesis recipients who will undergo training in their use and then be allowed to
evaluate the system in their home and community environment. Through these evaluations the end utility of the
system in real-world use will be evaluated.
项目总结/摘要
拟议的项目涉及一种有前途的新型热/视觉成像系统的商业化,
用作视觉假体和其他低视力辅助设备的输入模态。视觉假体,包括第二
Sight的Argus® II视网膜假体,可为因视网膜炎等疾病而失明的人恢复部分视力
色素变性和黄斑变性,以及Second Sight的Orion®视觉皮层假体,
对因视网膜色素变性、黄斑变性、青光眼等疾病而失明的人的部分视力,
糖尿病视网膜病变、眼损伤/外伤、视神经疾病等,使用摄像头或其他传感器来提供
直接对用户的视网膜或视觉皮层进行电刺激以引起视觉感知。不幸的是,
普通的光和颜色信息对于佩戴者来说难以在许多重要任务中有效地处理,
假体和其他低视力辅助设备的有限的感知空间分辨率。电流补偿
降低分辨率系统中的技术应用可见光的增强、放大和平移
图像,这些技术具有实用性。然而,正如我们在第一和第二阶段令人信服地表明,
在SBIR支持的开发项目中,其他类型的成像更自然地与有限的
视觉假体在重要任务中的分辨率,例如人员查找和移动性。在本拟议CRP中,
项目,我们将推进第二阶段开发的生产原型系统进入商业生产,
完成所有要求的验证和确认测试,以获得FDA批准。完成生产
系统将分发给假肢接受者,他们将接受使用培训,然后被允许
在家庭和社区环境中评估系统。通过这些评估,
在现实世界中使用的系统将被评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory John Seifert其他文献
Gregory John Seifert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory John Seifert', 18)}}的其他基金
Low-Cost, Portable, Point of Care Amplitude-Integrated Electroencephalography (aEEG)
低成本、便携式、床旁幅值积分脑电图 (aEEG)
- 批准号:
9315618 - 财政年份:2015
- 资助金额:
$ 73.11万 - 项目类别:
Custom Fit 3D-Printed Pediatric Respiratory Masks
定制 3D 打印儿童呼吸面罩
- 批准号:
9012431 - 财政年份:2015
- 资助金额:
$ 73.11万 - 项目类别:
Low-Cost, Portable, Point of Care Amplitude-Integrated Electroencephalography (aEEG)
低成本、便携式、床旁幅值积分脑电图 (aEEG)
- 批准号:
9194546 - 财政年份:2015
- 资助金额:
$ 73.11万 - 项目类别:
Distance Bounded Impulse Radio for Continuous Glucose Sensor
用于连续血糖传感器的距离限制脉冲无线电
- 批准号:
8780544 - 财政年份:2014
- 资助金额:
$ 73.11万 - 项目类别:
Distance Bounded Impulse Radio for Continuous Glucose Sensor
用于连续血糖传感器的距离限制脉冲无线电
- 批准号:
8927617 - 财政年份:2014
- 资助金额:
$ 73.11万 - 项目类别:
Retinal Prosthesis with Enhanced Thermal Imaging
具有增强热成像功能的视网膜假体
- 批准号:
8714976 - 财政年份:2014
- 资助金额:
$ 73.11万 - 项目类别:
Retinal Prosthesis with Enhanced Thermal Imaging
具有增强热成像功能的视网膜假体
- 批准号:
9265861 - 财政年份:2014
- 资助金额:
$ 73.11万 - 项目类别:
Distance Bounded Impulse Radio For Continuous Glucose Sensor
用于连续血糖传感器的距离限制脉冲无线电
- 批准号:
8453703 - 财政年份:2013
- 资助金额:
$ 73.11万 - 项目类别:
Tools for Coordination Among Caregivers of Alzheimer's Disease Patients
阿尔茨海默病患者护理人员之间的协调工具
- 批准号:
8464462 - 财政年份:2012
- 资助金额:
$ 73.11万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 73.11万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 73.11万 - 项目类别: